Analyst Consensus ?
ConsensusBuy25 ratings
Bullish2184.0%
Neutral416.0%
Bearish00.0%
FN2 Earnings Intelligence
Bunge Global S.A. (BG) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 29, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Overweight | Overweight | Maintain | Oct 12, 2026 |
| UBS | Buy | Buy | Maintain | Sep 10, 2026 |
| Barclays | Overweight | Overweight | Maintain | Apr 30, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Mar 11, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Mar 11, 2026 |
| B of A Securities | Buy | Buy | Maintain | Dec 2, 2025 |
| Stephens & Co. | Overweight | Overweight | Maintain | Oct 17, 2025 |
| Citigroup | Neutral | Neutral | Maintain | Apr 15, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Feb 13, 2024 |
| HSBC | Buy | Hold | Upgrade | Feb 9, 2024 |
| Roth MKM | Buy | Buy | Maintain | Feb 5, 2024 |
| Baird | Neutral | Neutral | Maintain | Jan 23, 2024 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jan 10, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Jun 23, 2022 |
| Bank of America | Buy | Neutral | Upgrade | Aug 2, 2016 |
| BB&T Capital | Buy | Buy | Maintain | Jul 12, 2016 |
| Macquarie | Outperform | Outperform | Maintain | Oct 29, 2015 |
| Vertical Research | Buy | Buy | Maintain | Jul 7, 2015 |
| Feltl & Co. | Buy | Hold | Upgrade | Oct 23, 2013 |
| Miller Tabak | Hold | Buy | Downgrade | Oct 21, 2013 |
| PiperJaffray | Overweight | Neutral | Upgrade | Jun 12, 2013 |
| Piper Sandler | Overweight | Neutral | Upgrade | Jun 11, 2013 |
| Topeka | Buy | Hold | Upgrade | Jul 30, 2012 |
| Topeka Capital | Buy | Hold | Upgrade | Jul 29, 2012 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Apr 29, 2012 |
Upside is calculated against the persisted previous close $100.8. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Manav Gupta | $155 | $123.5 | +53.8% | Sep 10, 2026 |
| UBS | Manav Gupta | $115 | $123.5 | +14.1% | Sep 10, 2026 |
| BMO Capital | Andrew Strelzik | $150 | $113.68 | +48.8% | Aug 13, 2026 |
| Barclays | Analyst unavailable | $150 | $126.31 | +48.8% | Apr 30, 2026 |
| Morgan Stanley | Steven Haynes | $130 | $112.75 | +29.0% | Mar 5, 2026 |
| UBS | Analyst unavailable | $145 | $117.23 | +43.8% | Feb 5, 2026 |
| BMO Capital | Analyst unavailable | $130 | $117.23 | +29.0% | Feb 5, 2026 |
| Stephens | Analyst unavailable | $130 | $117.23 | +29.0% | Feb 5, 2026 |
| Coker Palmer | Thomas Palmer | $117 | $110.06 | +16.1% | Jan 21, 2026 |
| Morgan Stanley | Analyst unavailable | $95 | $97.6 | -5.8% | Oct 27, 2025 |
| Barclays | Benjamin Theurer | $105 | $97.25 | +4.2% | Oct 21, 2025 |
| Stephens | Analyst unavailable | $115 | $95.33 | +14.1% | Oct 17, 2025 |
| BMO Capital | Analyst unavailable | $110 | $93.09 | +9.1% | Oct 16, 2025 |
| Morgan Stanley | Steven Haynes | $83 | $83.14 | -17.7% | Aug 12, 2025 |
| CFRA | Arun Sundaram | $90 | $85.86 | -10.7% | Oct 30, 2024 |
| HSBC | Wesley Brooks | $105 | $104.06 | +4.2% | Apr 25, 2024 |
| Coker Palmer | Thomas Palmer | $122 | $105.79 | +21.0% | Apr 24, 2024 |
| UBS | Analyst unavailable | $133 | $94.47 | +31.9% | Dec 14, 2022 |
| Morgan Stanley | Analyst unavailable | $120 | $115.76 | +19.0% | May 2, 2022 |
| Credit Suisse | Analyst unavailable | $140 | $116.4 | +38.9% | Apr 28, 2022 |
| BMO Capital | Analyst unavailable | $144 | $118.96 | +42.9% | Apr 28, 2022 |
| Barclays | Analyst unavailable | $135 | $115.56 | +33.9% | Apr 25, 2022 |
Track every rating change on BG the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.